GHCM
EXAS

Glen Harbor Capital Management’s Exact Sciences EXAS Stock Holding History

Glen Harbor Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$29.1M Sell
322,558
-18,360
-5% -$2.09M 0.61% 43
2019
Q2 		$40.2M Sell
340,918
-30,940
-8% -$3.12M 0.84% 22
2019
Q1 		$32.2M Sell
371,858
-2,788
-0.7% -$237K 0.69% 33
2018
Q4 		$23.6M Sell
374,646
-2,380
-0.6% -$163K 0.57% 39
2018
Q3 		$29.8M Buy
377,026
+42,296
+13% +$2.76M 0.6% 35
2018
Q2 		$20M Sell
334,730
-15,606
-4% -$840K 0.43% 56
2018
Q1 		$14.1M Buy
350,336
+11,594
+3% +$566K 0.32% 70
2017
Q4 		$17.8M Sell
338,742
-13,940
-4% -$744K 0.4% 60
2017
Q3 		$16.6M Buy
352,682
+6,426
+2% +$259K 0.4% 64
2017
Q2 		$12.2M Buy
346,256
+85,952
+33% +$2.65M 0.3% 68
2017
Q1 		$6.15M Buy
260,304
+68,850
+36% +$1.36M 0.15% 130
2016
Q4 		$2.56M Buy
+191,454
New +$3.09M 0.07% 228

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Glen Harbor Capital Management's EXAS Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Exact Sciences (EXAS) stake by 5.4% in Q3 2019, selling an estimated $2.09M and leaving 322,558 shares worth $29.1M. The position accounts for 0.61% of the portfolio, ranked #43.

Glen Harbor Capital Management first reported a position in EXAS in Q4 2016 and has held it in 12 quarters since. The position peaked at $40.2M in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Glen Harbor Capital Management held 322,558 shares of Exact Sciences worth $29.1M as of Q3 2019.
  • Glen Harbor Capital Management sold 18,360 Exact Sciences shares in Q3 2019, an estimated $2.09M.
  • Exact Sciences made up 0.61% of Glen Harbor Capital Management's portfolio in Q3 2019, its #43 holding.
  • Glen Harbor Capital Management first reported a position in Exact Sciences in Q4 2016 and has held it in 12 quarters since.
  • Glen Harbor Capital Management's Exact Sciences position peaked at $40.2M in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.